Intraoperative Parathyroid Hormone Monitoring Corroborates the Success of Parathyroidectomy in Children

Similar documents
Minimally invasive parathyroidectomy

hypercalcemia of malignancy hyperparathyroidism PHPT the most common cause of hypercalcemia in the outpatient setting the second most common cause

RADIOGUIDED PARATHYROIDECTOMY IS SUCCESSFUL IN 98.7% OF SELECTED PATIENTS

Case 2: 30 yr-old woman with 7 yr history of recurrent kidney stones

HPI joint pain/arthritis serum calcium 11.5 PTH 147pg/ml

Outline. Parathyroid Localization Studies. Mira Milas MD, FACS Associate Professor of Surgery Director, The Thyroid Center

PAPER. The Effectiveness of Radioguided Parathyroidectomy in Patients With Negative Technetium Tc 99m Sestamibi Scans

Complementary sestamibi scintigraphy and ultrasound for primary hyperparathyroidism

HYPERPARATHYROIDIS M FAISAL GHANI SIDDIQUI MBBS; FCPS; PGDIP-BIOMEDICAL ETHICS; MCPS-HPE

Role of Imaging in the Localization of Parathyroid Adenoma

ORIGINAL ARTICLE. An Optimal Algorithm for Intraoperative Parathyroid Hormone Monitoring

4/20/2015. The Neck xt Exploration: Intraoperative Parathyroid Hormone (IOPTH) Testing During Surgical Parathyroidectomy. Learning Objectives

Clinical Medicine Insights: Endocrinology and Diabetes 2013:6

Parathyroid Imaging. A Guide to Parathyroid Surgery

Normal PTH Levels in Primary Hyperparathyroidism: Still the Same Disease?

PRIMARY HYPERPARATHYROIDISM

Perioperative parathormone assessment during surgery for primary hyperparathyroidism;

Preoperative Tc-99m-sestamibi (MIBI) scintigraphy and

Case 4: 27 yr-old woman with history of kidney stones and hyperparathyroidism.

Marcin Barczynski, 1 Aleksander Konturek, 2 Alicja Hubalewska-Dydejczyk, 2. Filip Gołkowski, 1 Stanislaw Cichon, 1 Piotr Richter, 1 Wojciech Nowak

Peroperative PTH testing:

Minimally invasive surgery for primary hyperparathyroidism with or without intraoperative parathyroid hormone monitoring

The parathyroid glands participate in the regulation

The CaPTHUS Scoring Model revisited: Applicability from. with Primary Hyperparathyroidism

ORIGINAL ARTICLE. Sestamibi Scans and Intraoperative Parathyroid Hormone Measurement in the Treatment of Primary Hyperparathyroidism

Approach to a patient with hypercalcemia

Use of PTH at Point of Surgery for Non-Localized Cases of Hyperparathyoidism

Primary hyperparathyroidism (HPT) has an incidence of

Effect of open minimally invasive parathyroidectomy in the management of primary hyperparathyroidism

Research Article Primary Hyperparathyroidism: 11-Year Experience in a Single Institute in Thailand

Abhijit Thakur Æ Frederic Sebag Æ Eveline Slotema Æ Giuseppe Ippolito Æ David Taïeb Æ Jean François Henry

Hyperparathyroidism: Operative Considerations. Financial Disclosures: None. Hyperparathyroidism. Hyperparathyroidism 11/10/2012

PTH > 60pg/ml PRIMARY HYPERPARATHYROIDISM. Introduction Biochemical Diagnosis. Normal Parathyroid. Parathyroid Glands

IMPACT OF CONCOMITANT THYROID PATHOLOGY ON PREOPERATIVE WORKUP FOR PRIMARY HYPERPARATHYROIDISM

The current status of intraoperative ipth assay in surgery for primary hyperparathyroidism

Hyperparathyroidism. When to Suspect, How to Diagnose, When and How to Intervene. Johanna A. Pallotta, MD, FACP, FACE

ORIGINAL ARTICLE. Persistent Parathyroid Hormone Elevation Following Curative Parathyroidectomy for Primary Hyperparathyroidism

Preoperative Localization and Intraoperative Parathyroid Hormone Assay in Korean Patients with Primary Hyperparathyroidism

Thallium 201 scanning can diagnose multiple recurrences in forearm implanted parathyroid tissue post total parathyroidectomy:

Women s Health in General Practice Symposium 2015 Thyroid & Parathyroid Cases

PAPER. John I. Lew, MD; Mariela Rivera, MD; George L. Irvin III, MD; Carmen C. Solorzano, MD

"Asymptomatic" Hyperparathyroidism: Reasons for Parathyroidectomy

A large parathyroid adenoma presenting with pathological fractures in a young male

Intraoperative parathyroid hormone level in parathyroidectomy: which patients benefit from it?

PARATHYROID NUCLEAR MEDICINE IMAGING REVIEW DISCLOSURES

PRIMARY HYPERPARATHYROIDISM PRIMARY HYPERPARATHYROIDISM. Hyperparathyroidism Etiology. Common Complex Insidious Chronic Global Only cure is surgery

Potential conflicts of interest: None

NEOPLASMS OF THE THYROID PATHOLOGY OF PARATHYROID GLANDS. BY: Shifaa Qa qa

Cases in Endocrinology

Re-explorative Parathyroid Surgery for Persistent and Recurrent Primary Hyperparathyroidism

Southern Derbyshire Shared Care Pathology Guidelines. Primary Hyperparathyroidism

B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life.

PRIMARY HYPERPARATHYROIDISM WITH RICKETS. KRITHIKA.P Dr.L.N.Padmasani Unit 1 Sri Ramachandra Medical College

General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons

Coexistence of parathyroid adenoma and papillary thyroid carcinoma. Yong Sang Lee, Kee-Hyun Nam, Woong Youn Chung, Hang-Seok Chang, Cheong Soo Park

Health Sciences Centre, Team A, Dr. L. Bohacek (Endocrine Surgery) Medical Expert

Parathyroid Imaging What is best

Minimally invasive parathyroidectomy with or without intraoperative parathyroid hormone for primary hyperparathyroidism

Comparison Of Sestamibi Scintigraphy And Ultrasonography In Preoperative Localization Of Primary Hyperparathyroidism

Minimally invasive parathyroid surgery

Hypercalcemia. Hypercalcemia: When to Worry, When to Treat! Mineral Metabolism : A Short Course

Surgical Outcome of Patients with Hyperparathyroidism in a Non-Specialist Surgical Ward

Surgical treatment of primary hyperparathyroidism due to parathyroid tumor: A 15-year experience

Primary Hyperparathyroidism

A 20-Year Study on 190 Patients With Primary Hyperparathyroidism in a Developing Country: Turkey Experience

THE PARATHYROID GLAND THEORY AND NUCLEAR MEDICINE PRACTICE

Parathyroid Glands: location, condition and value of imaging tests.

Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital

Case Report A Reference Finding Rarely Seen in Primary Hyperparathyroidism: Brown Tumor

Clinical Approach to Hypercalcemia For the Primary Care Provider

Surgery for Primary Hyperparathyroidism

News on the treatment of HPT

PARATHYROID IMAGING. James Lee, MD Chief, Endocrine Surgery Co-Director NY Thyroid-Parathyroid Center Columbia University Medical Center

Cover Page. The handle holds various files of this Leiden University dissertation.

Parathyroid Disease Scenarios for the Practicing Clinician. Vijaya Chockalingam MD Faculty Endocrinologist Banner University Medical Center- Phoenix

A Move Towards Focused Parathyroidectomy in BSMMU Even Under Local Anesthesia

O~iginalArtrc!~'" MINIMALLY INVASIVE RADIO-GUIDED PARATHYROIDECTOMY IN 152 CONSECUTIVE PATIENTS WITH PRIMARY HYPERPARATHYROIDISM

Bone and Renal Stone Disease in Patients Operated for Primary Hyperparathyroidism in Pakistan: Is the Pattern of Disease different from the West?

Primary Hyperparathyroidism

The disease spectrum in primary hyperparathyroidism

ORIGINAL ARTICLE. Novel Parathyroid Hormone (1-84) Assay as Basis for Parathyroid Hormone Monitoring in Renal Hyperparathyroidism

Parathyroid Imaging: Current Concepts. Maria Gule-Monroe, M.D. Nancy Perrier, M.D.

Dilemma in diagnosing thyroid adenoma A case report

THE ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM WITH DISORDERS OF THE THYROID GLAND AND CARPENTRY OUR EXPERIENCE

Efficacy of intraoperative parathyroid hormone monitoring to predict success of parathyroidectomy for secondary hyperparathyroidism

USEFULNESS OF INTRAOPERATIVE PARATHYROID HORMONE MONITORING DURING MINIMALLY INVASIVE VIDEO-ASSISTED PARATHYROIDECTOMY

Clinical impact of two different intraoperative parathyroid hormone assays in primary and renal hyperparathyroidism

The surgical management of patients with primary hyperparathyroidism

Hyperparathyroidism (primary): diagnosis, assessment and initial management

Parathyroidectomy. Surgery for Parathyroid Problems

INDEX. Note: Page numbers of issue and article titles are in boldface type. cell carcinoma. ENDOCRINE SURGERY

CURRENTLY THERE is considerable discussion about

Six hundred fifty-six consecutive explorations for primary hyperparathyroidism Udelsman R

HYPERCALCEMIA. Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences

ORIGINAL ARTICLE. Appearance of Ectopic Undescended Inferior Parathyroid Adenomas on Technetium Tc 99m Sestamibi Scintigraphy

The mystery of the hidden parathyroid adenoma. Case #1. Imaging. Case of missed adenoma. Ultrasound false nega9ves. Case of missed adenoma 5/16/16

Intraoperative Parathyroid Hormone Testing: Who Should Be the Target?

Primary hyperparathyroidism in Hong Kong: an analysis of 44 cases

E. Ypsilantis, 1 H. Charfare, 2 andw.s.wassif Introduction

This PDF is available for free download from a site hosted by Medknow Publications

Transcription:

J Clin Res Pediatr Endocrinol 2014;6(3):158-162 DO I: 10.4274/jcrpe.1401 Original Article Intraoperative Hormone Monitoring Corroborates the Success of ectomy in Children Ahmet Çelik1, Emre Divarcı1, Zafer Dökümcü1, Orkan Ergün1, Samim Özen2, Damla Gökşen2, Şükran Darcan2, Yeşim Ertan3 1 Ege University Faculty of Medicine, Department of Pediatric Surgery, İzmir, Turkey 2 Ege University Faculty of Medicine, Department of Pediatric Endocrinology, İzmir, Turkey 3 Ege University Faculty of Medicine, Department of Pathology, İzmir, Turkey ABSTRACT Objective: To assess the efficacy of intraoperative parathyroid hormone (PTH) monitoring in evaluating the outcome of parathyroidectomy in pediatric patients. Methods: Intraoperative PTH monitoring during parathyroidectomy was performed in five children (3M, 2F); three had parathyroid s (single gland disease) and two had primary hyperplasia. One patient had undergone two previous surgical interventions to remove the parathyroid glands, but the PTH levels had remained high with persistence of symptoms. Immunoradiometric analysis was used for PTH measurements. Preoperative PTH values were obtained to monitor the baseline levels. Serum samples were collected 20 minutes after removal of the /parathyroid gland(s) and PTH levels were compared with preoperative values. Specimens were also confirmed by frozen sectional examination. Results: Mean age of the patients was 11 years (range: 3 months-16 years). Mean preoperative PTH values were 633.3±579 pg/ml (range: 143-1300 pg/ml). Intraoperative values decreased to 18.7±5.5 pg/ml (range: 8-27 pg/ml) following removal of the gland(s). Normal calcium levels were achieved with adequate management following surgery. One patient (with multiple surgeries and found to have an ectopic parathyroid gland) had hungry bone syndrome after the operation and was treated successfully. There were no major complications. All patients maintained normal calcium/ phosphorus levels in the follow-up period, ranging from 2 to 5 years. Conclusion: An ectopic parathyroid gland or another undetected can be overlooked during surgery. Owing to the short life of the hormone, intraoperative PTH monitoring to determine PTH clearance proved to be a feasible marker for adequacy and safety of surgery and cure. Key words: hormone, hyperparathyroidism, parathyroid, parathyroidectomy Conflict of interest: None declared Received: 21.04.2014 Accepted: 10.07.2014 Introduction Primary hyperparathyroidism (PHPT) is characterized by overproduction of parathyroid hormone (PTH) from abnormal parathyroid gland(s). This is a very rare disorder in childhood - approximately 1%-2% of all patients with PHPT are children. Deleterious effects of PHPT can be seen especially in the urinary system and bone tissue (1). Removal of abnormal functioning parathyroid gland(s) is the main objective in the treatment of PHPT. Surgical excision should be performed by conventional technique as bilateral neck exploration or minimally invasive parathyroidectomy (2,3,4,5). The removal of all abnormal functioning parathyroid tissue is necessary to achieve a satisfactory result. In recent years, PTH monitoring during parathyroidectomy became more popular in adults to improve cure rates (4,6,7,8). There are very few reports about PTH monitoring in childhood (5). In this study, we aimed to report the efficacy of intraoperative PTH monitoring as a useful adjunct to corroborate the success of parathyroidectomy in children with PHPT. Methods Five pediatric patients (3M, 2F) with PHPT were treated surgically in our institution between 2006 and 2010. The diagnosis was confirmed by laboratory tests [calcium (Ca), PTH Address for Correspondence Ahmet Çelik MD, Ege University Faculty of Medicine, Department of Pediatric Surgery, İzmir, Turkey Phone: +90 535 726 87 63 E-ma il: ahmet.celik@ege.edu.tr This study was presented European Association of Pediatric Surgeons (EUPSA) Congress 2009, Graz, AT Jo ur nal of Cli ni cal Re se arch in Pe di at ric En doc ri no logy, Pub lis hed by Ga le nos Pub lis hing. 158

levels] and imaging studies in patients with the clinical signs of hypercalcemia. Patients were examined by neck ultrasonography (USG) and MIBI-scintigraphy in routine preoperative work-up. Computerized tomography (CT) or magnetic resonance imaging (MRI) were also used if the localization of the lesion was uncertain. Patients underwent medical therapy with 4 diuretic and bisphosphonate before surgery. Intraoperative PTH monitoring is used as a standard procedure during parathyroidectomy. PTH levels are measured by immunoradiometric analysis before and during surgery. Normal PTH level reference was accepted as 10-65 pg/ml. Baseline PTH levels were obtained from all patients preoperatively and 20 minutes after resection of the lesion, serum PTH levels were checked again. Excised tissue underwent frozen sectional examination simultaneously during the surgery. The surgical approach consisted of limited neck exploration with single-gland parathyroidectomy in patients with isolated as assessed by preoperative work-up studies and total parathyroidectomy with autotransplantation for patients with multiple gland disease or hyperplasia. In our study, a curative resection was defined as more than a 90% decrease in PTH levels at 20 minutes following the resection, compared to baseline (9). If PTH levels failed to decrease, exploration for an additional hyper-functioning parathyroid tissue was deemed necessary. After resection of the additional lesion, PTH levels were checked again. This procedure was continued until achieving more than 90% decrease in PTH levels. Serum Ca and PTH levels were followed regularly after surgery. The data were reported as mean ± standard error of the mean. the final operation, she underwent total thyroidectomy for the possibility of ectopic localization, but PTH levels failed to decrease. Persistent exploration for an ectopic parathyroid tissue became necessary and finally, an ectopic tissue was found close to the common carotid artery. This lesion was confirmed to be parathyroid tissue by frozen section examination and more than 90% decrease in PTH levels was achieved ultimately. A normal Ca level was achieved by medical replacement therapy in this patient. The clinical disorders leading to hyperparathyroidism were solitary s in three patients and primary hyperplasia in two patients. After removal of the lesions, preoperative PTH levels decreased significantly from 633.3±579 pg/ml to 8.7±5.5 pg/ml (>90%) (Figure 1). Similarly, preoperative Ca levels decreased to normal levels after surgery. No major complications occurred after surgery. Only one patient with multiple surgeries had hungry bone syndrome after the operation but was treated successfully with medical treatment. Patient 3 with primary hyperplasia necessitated continuous oral Ca supplementation postoperatively. All patients had normal Ca and PTH levels at postoperative follow-up (2-5 years). Discussion PHPT is defined as excessive secretion of PTH from the parathyroid gland(s). It is characterized by hypercalcemia, increased levels of PTH and slight hypophosphatemia (10). Bone diseases and nephrolithiasis are the major clinical conditions caused by PHPT. Peptic ulcer, hypertension, weakness, weight Results The patients mean age was 11 years and ranged from age 3 months to 16 years. Major presenting symptoms were listed as headache, abdominal pain, feeding intolerance, mental retardation and walking difficulty (Table 1). Only one patient had a palpable nodule on physical examination. The other patients had no physical signs. None of the patients had a family history of parathyroid disease. Hyperparathyroidism was diagnosed by laboratory tests as hypercalcemia and increased levels of PTH. Detailed neck USG demonstrated parathyroid s in three patients. Patient 3 had primary hyperplasia, but no lesion could be demonstrated on imaging studies preoperatively. In this patient, total parathyroidectomy was performed by bilateral exploration and half of the one gland was grafted to the left forearm. A significant decrease of PTH level occurred following the total excision. Patient 4 had persistent hypercalcemia, but no pathological lesions were demonstrated by radiological investigations. This patient had primary hyperplasia and had undergone two previous insufficient parathyroidectomies in our clinic previously. At Preoperative PTH 20 th minute PTH after removal of gland Figure 1. The significant decrease in intraoperative PTH levels after removal of the pathological parathyroid tissues 159

loss, anorexia, constipation, vomiting, pathological bone fractures, hematuria and polyuria can also develop frequently in these patients. PHPT and its diagnosis in children is quite rare (11).The largest series to date limited to strictly pediatric patients (5-19 years old) comprised 52 patients, encountered in the course of a 30-year period (12). Disorders that can cause PHPT in adulthood are listed as solitary s (90%), primary hyperplasia (9%-10%), and parathyroid carcinomas (0.5%-1%) (13,14). In children, the majority of the lesions (65%) are solitary s, followed by hyperplasia (27%) (12). Several genetic diseases can be seen in children with hyperparathyroidism. Familial hypocalciuric hypercalcemia is caused by the mutation of the Ca-sensitive receptor gene. In homozygous cases, the patients present with excessive hypercalcemia and increased PTH levels in the neonatal period (15,16,17). The heterozygous cases are generally asymptomatic and diagnosed incidentally at any age (17). MEN1, MEN2A and familial hyperparathyroidism are other inherited diseases which can present with hyperparathyroidism in childhood. Operative treatment for PHPT in children is individualized but can vary from single-gland parathyroidectomy for isolated to subtotal or total parathyroidectomy with autotransplantation for hyperplasia. The overall success rate of surgical treatment at PHPT in pediatric patients is excellent. The use of preoperative localization imaging with sestamibi scintigraphy or high-resolution USG coupled with intraoperative PTH assay has made more minimally invasive unilateral image-guided explorations possible in highly selected patients (12). In appropriate patients, this has been our preferred approach. However, traditional bilateral neck exploration remains the standard approach, especially for patients with suspected multiglandular disease. Table 1. The demographic data of the patients Diagnosis Patient 1 Patient 2 Patient 3 Patient 4 Primary hyperparathyroidism Primary hyperparathyroidism Patient 5 Age 16 years 16 years 3 months 9 years 14 years Gender M M M F F Presenting symptoms Headache Abdominal pain Feeding intolerance, irritability Mental retardation Walking difficulty Physical examination Normal Palpable nodule Normal Normal Normal History None Polycystic renal disease, nephrolithiasis Hyperbilirubinemia Two previous unsuccessful parathyroidectomies Bone cysts USG results Adenoma Adenoma Normal Normal Adenoma Scintigraphy results Hyperfunctional parathyroid gland Increased retention None Normal None Operation Adenoma excision Adenoma excision Total parathyroidectomy + autotransplantation Preoperative Ca/P levels (mg/ml) Total thyroidectomy + ectopic excision Adenoma excision 12.4/3.2 12.2/3.1 17.4/2.6 13.5/2.5 12.4/2.9 Preoperative PTH level (pg/ml) 20 th minute PTH level (pg/ml) 219.5 143.0 1230.0 274.0 1300.0 20.9 13.0 8.0 24.0 27.0 Follow-up period 4 years 2.5 years 4 years 5 years 2 years USG: ultrasonography, PTH: parathyroid hormone 160

Table 2. A summary of results of recent studies on parathyroidectomy in children (<18 yrs) Libansky et al (1) Durkin et al (5) Kollars et al (12) Our study Diagnosis Primary hyperparathyroidism Primary hyperparathyroidism Primary hyperparathyroidism Primary hyperparathyroidism Number of patients 10 12 52 5 Surgical technique Bilateral neck exploration Minimally invasive parathyroidectomy* Cervical exploration Unilateral or bilateral neck exploration Intraoperative PTH monitoring** - + - + Cure rate*** 9/10 (90%) 12/12 (100%) 46/52 (94%) 5/5 (100%) * One patient required bilateral neck exploration during surgery ** Intraoperative PTH monitoring at the first operation *** At the first operation The main objective in the treatment of PHPT is to remove all of the hyper-functioning parathyroid tissues. This can be accomplished by conventional bilateral neck exploration or minimally invasive technique. In adulthood, a 94% cure rate was achieved by bilateral neck exploration (18). There are very few reports on results of surgical treatment in children with PHPT due to the rarity of this condition in the pediatric population (Table 2) (1,5,12). Several options have been reported for timing of PTH testing during surgery (7,8). Many surgeons accept a successful resection as more than a 50% decrease at the 10 th minute, but this could be misleading in multi-glandular disease (6,7,8). In our study, a curative resection is defined as a more than 90% decrease in PTH levels from baseline at 20 minutes following resection (9). If PTH levels failed to decrease, exploration for an additional hyper-functioning parathyroid tissue was deemed necessary. After resection of the additional lesion, PTH levels were checked again and the procedure continued until achievement of a more than 90% decrease in PTH levels. Libansky et al (1) performed bilateral neck exploration for treatment of PHPT in 10 children. These authors did not use intraoperative PTH monitoring during surgery. Nine of these patients were treated successfully by one single operation, but one patient necessitated reoperation due to persistent hyperparathyroidism. In the second operation, they performed intraoperative PTH testing and found an ectopic parathyroid tissue within the carotid sheath, a finding similar to one of the patients in our series. Minimally invasive parathyroidectomy (MIP) was performed in 12 children by Durkin et al (5). This team preferred to perform MIP in patients with lesions which were localized by preoperative imaging studies (USG or Technetium- 99m sestamibi scanning). Eleven of the 12 patients were treated by MIP successfully (11/12, or 89%). One patient required conversion to bilateral neck exploration due to inadequate decrease in PTH levels (<50% in 15 th minute). In our study, three children with solitary underwent MIP. Two patients with primary hyperplasia necessitated total parathyroidectomy with autotransplantation by bilateral neck exploration. Patient 4 had two previous unsuccessful parathyroidectomies, but the hyperparathyroidism persisted. At the third operation, due to the possibility of an ectopic localization, a total thyroidectomy was performed, but PTH measurements failed to decrease intraoperatively. So, we continued to explore for an ectopic parathyroid tissue and ultimately found an ectopic tissue situated close to the common carotid artery. In conclusion, our results show that an effective treatment was achieved in all our patients by intraoperative PTH monitoring, with assistance of frozen-section pathological evaluation during parathyroidectomy. Thus, despite the low number of patients in this series, we would recommend intraoperative PTH monitoring to corroborate the success of parathyroidectomy in children. References 1. Liba nsky P, Astl J, Ada mek S, Nanˇka O, Pafko P, Sˇpacˇkova J, Folta n R, Sıˇedy J. Surgical treatment of primary hyperparathyroidism in children: Report of 10 cases. Int J Pediatr Otorhinolaryngol 2008;72:1177-1182. 2. Chen H, Mack E, Starling JR. Radioguided parathyroidectomy is equally effective for both tous and hyperplastic glands. Ann Surg 2003;238:332-337. 3. Udelsman R. Six hundred fifty- six consecutive explorations for primary hyperparathyroidism. Ann Surg 2002;235:665-670. 4. Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 2005;138:583-587. 5. Durkin ET, Nichol PF, Lund DP, Chen H, Sippel RS. What is the optimal treatment for children with primary hyperparathyroidism? J Pediatr Surg 2010;45:1142-1146. 161

6. Siperstein A, Berber E, Barbosa GF, Tsinberg M, Greene AB, Mitchell J, Milas M. Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg 2008;248:420-428. 7. Richards ML, Thompson GB, Farley DR, Grant CS. An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg 2011;146:280-285. 8. Meyer SK, Zorn M, Frank-Raue K, Büchler MW, Nawroth P, Weber T. Clinical impact of two different intraoperative parathyroid hormone assays in primary and renal hyperparathyroidism. Eur J Endocrino. 2009;160:275-281. Epub 2008 Nov 12 9. Weber T, Zeier M, Hinz U, Schilling T, Büchler MW. Impact of intraoperative parathyroid hormone levels on surgical results in patients with renal hyperparathyroidism. World J Surg 2005;29:1176-1179. 10. Adámek S, Vavrík J, Schützner J, Broulík P, Belsan T. Importance and reliability of localization examinations in primary hyperparathyroidism. Sb Lek 2000;101:289-295. 11. Li CC, Yang C, Wang S, Zhang J, Kong XR, Ouyang J. A 10-year retrospective study of primary hyperparathyroidism in children. Exp Clin Endocrinol Diabetes 2012;120:229-233. Epub 2012 Feb 10 12. Kollars J, Zarroug AE, van Heerden J, Lteif A, Stavlo P, Suarez L, Moir C, Ishitani M, Rodeberg D. Primary hyperparathyroidism in pediatric patients. Pediatrics 2005;115:974-980. 13. Milas M, Wagner K, Easley KA, Siperstein A, Weber CJ.Double s revisited: nonuniform distribution favors enlarged superior parathyroids (fourth pouch disease). Surgery 2003;134:995-1003. 14. Snell SB, Gaar EE, Stevens SP, Flynn MB. cancer, a continued diagnostic and therapeutic dilemma: report of four cases and review of the literature. Am Surg 2003;69:711-716. 15. Fox L, Sadowsky J, Pringle KP, Kidd A, Murdoch J, Cole DE, Wiltshire E. Neonatal hyperparathyroidism and pamidronate therapy in an extremely premature infant. Pediatrics 2007;120:1350-1354. 16. Hu J, Spiegel AM. Structure and function of the human calciumsensing receptor: insights from natural and engineered mutations and allosteric modulators. J Cell Mol Med 2007;11:908-922. 17. Bringhurts FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism., in: P.R. Larsen, H.M. Kronenberg (Eds.), Williams Textbook of Endocrinology 2003:1303-1373. 18. Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 2002;236:543-551. 162